3-((5-Amino-1,3,4-thiadiazol-2-yl)thio)-N-(2,5-dimethylphenyl)propanamide

Catalog No. :
ACVYFM417
CAS No. :
889947-90-4
Molecular Formula :
C13H16N4OS2
Molecular Weight :
308.43

IUPAC Name:3-((5-amino-1,3,4-thiadiazol-2-yl)thio)-N-(2,5-dimethylphenyl)propanamide

3-((5-Amino-1,3,4-thiadiazol-2-yl)thio)-N-(2,5-dimethylphenyl)propanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$193.00Login to see priceInquiryInquiry
1g95%$441.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-((5-Amino-1,3,4-thiadiazol-2-yl)thio)-N-(2,5-dimethylphenyl)propanamide
IUPAC Name3-((5-amino-1,3,4-thiadiazol-2-yl)thio)-N-(2,5-dimethylphenyl)propanamide
MDL No.MFCD08133408
Molecular FormulaC13H16N4OS2
Molecular Weight308.43
SMILESO=C(NC1=CC(C)=CC=C1C)CCSC2=NN=C(N)S2
InChI KeyDVIALZWNORIQCS-UHFFFAOYSA-N
Synonym3-[(5-AMINO-1,3,4-THIADIAZOL-2-YL)THIO]-N-(2,5-DIMETHYLPHENYL)PROPANAMIDE;propanamide, 3-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-(2;3-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-(2,5-dimethylphenyl)propanamide;3-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-(2,5-dimethylphenyl)propionamide;Oprea1_475495;Propanamide, 3-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-(2,5-dimethylphenyl)-
CAS No.889947-90-4

Synthetic Route by SureRoute

1. ACVYFM417 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVYFM417 route product structure diagram
    ACVYFM417889947-90-4
Inquiry

2. ACVYFM417 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVYFM417 route product structure diagram
    ACVYFM417889947-90-4
Inquiry

Comments (0)